Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares RepurchasedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares RepurchasedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Aclarion (ACON) Shares Issued (2021 - 2026)

Aclarion posted quarterly Shares Issued of $1.0 million for Q1 2026, up 207.93% year-on-year from $336441.0 in Q1 2025, and up 207.93% on a QoQ basis from $336441.0 in Q1 2025.

Aclarion (ACON) has 4 years of Shares Issued data on file, last reported at $1.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Issued rose 207.93% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 207.93% YoY), and the FY2025 full-year result was $336441.0, changed N/A from the prior year.
  • Shares Issued for Q1 2026 stood at $1.0 million, up from $336441.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.0 million in Q1 2026 and bottomed at -$47682.0 in Q2 2022.
  • The 3-year median for Shares Issued is $336441.0 (2025), against an average of $441586.3.
  • The widest annual swing landed in 2022, when Shares Issued slumped 305.19%; it then surged 207.93% in 2026.
  • A 3-year view of Shares Issued shows it stood at -$47682.0 in 2022, then jumped by 805.59% to $336441.0 in 2025, then soared by 207.93% to $1.0 million in 2026.
  • The last three Shares Issued figures came in at $1.0 million (Q1 2026), $336441.0 (Q1 2025), and -$47682.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 13.87 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 418,000.00
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 410,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -3.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.41 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 273,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 774,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 7.76 Mn
10 Aclarion 7.18 Mn -11.57 Mn 3,750.00 1.04 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.04 Mn
Mar 31, 2026 1.04 Mn
Mar 31, 2025 336,441.00
Mar 31, 2025 336,441.00
Jun 30, 2022 -47,682.00
Jun 30, 2022 -47,682.00
Sep 30, 2021 -30,393.00
Sep 30, 2021 -30,393.00
Jun 30, 2021 23,238.00
Jun 30, 2021 23,238.00
Mar 31, 2021 7,155.00
Mar 31, 2021 7,155.00